Liver disease is a growing health problem around the world, and one of the most common forms is nonalcoholic fatty liver disease, also known as NAFLD.
This condition happens when too much fat builds up inside the liver, even in people who drink little or no alcohol.
Many people with NAFLD may not notice symptoms at first. However, over time, the extra fat can damage the liver and lead to inflammation, scarring, and serious long-term health problems. In some cases, the disease can even increase the risk of liver cancer.
Doctors say NAFLD is becoming more common because of rising obesity rates, unhealthy diets, lack of exercise, and conditions such as diabetes. Millions of Americans are believed to have some form of fatty liver disease.
At an early stage, NAFLD can often be improved or even reversed through healthy lifestyle changes. Losing weight, exercising regularly, and eating healthier foods can reduce fat inside the liver and help prevent further damage.
However, the disease can sometimes progress into a much more serious condition called nonalcoholic steatohepatitis, or NASH. In NASH, the liver becomes inflamed and damaged, making it much harder to treat. Over time, NASH can lead to severe liver scarring, called cirrhosis, liver failure, or cancer.
One of the biggest challenges for doctors is that there are currently no fully approved medications specifically designed to treat NASH. Because of this, scientists are searching for new treatments that could stop or reverse the disease.
Now, researchers at Georgetown University have developed an experimental drug that may offer new hope.
The new drug is called CTPI-2. Scientists believe it works by targeting a gene called Slc25a1, which appears to play an important role in the development of fatty liver disease.
Genes are like instruction guides inside cells that control how the body functions. Researchers think the Slc25a1 gene may affect the way the body handles fat and inflammation in the liver.
To test the new drug, scientists carried out experiments in mice. Some mice were fed a high-fat diet designed to trigger fatty liver disease. Researchers then gave them CTPI-2 to see whether it could prevent the disease from developing.
In another set of experiments, the drug was tested on mice that already had severe liver damage similar to advanced NASH.
The results were very encouraging. The researchers found that CTPI-2 almost completely prevented mice on a high-fat diet from developing NASH. The treated mice also avoided becoming obese.
Even more impressive, the drug appeared to reverse liver damage in mice that already had advanced disease.
The treated mice also showed improvements in other important areas of health. They lost weight and had better control of blood sugar levels, which is important because diabetes and fatty liver disease are often closely connected.
The scientists also tested the drug in genetically modified mice and found similar results. These experiments suggested that CTPI-2 reduced inflammation in the liver and may even have anti-cancer effects.
Researchers believe the drug could possibly help fight several kinds of tumors, although much more research is needed before scientists know whether this effect could happen in humans.
Despite the exciting results, experts stress that the study was only performed in animals. Drugs that work well in mice do not always work the same way in people. Before CTPI-2 could ever become a treatment for patients, it would need to go through several stages of clinical trials to test its safety and effectiveness in humans.
For now, doctors still say that healthy lifestyle habits remain the best way to protect the liver and reduce the risk of fatty liver disease.
Experts recommend maintaining a healthy weight, eating a balanced diet, and exercising regularly. Foods rich in fruits, vegetables, whole grains, and fiber may help support liver health, while foods high in sugar, processed ingredients, and unhealthy fats may worsen fatty liver disease.
Regular physical activity is also important because exercise helps the body burn excess fat and improves blood sugar control.
Doctors also advise limiting alcohol consumption because heavy drinking can further damage the liver. Protecting against infections such as hepatitis A and hepatitis B is another important step for liver health.
People should also be careful when taking medications or supplements since some products can harm the liver if taken incorrectly or in large amounts.
Regular health check-ups may help detect liver problems earlier, before severe damage develops.
Although more research is needed, scientists say the discovery of CTPI-2 represents an important step toward finding the first effective treatment for NASH and other forms of fatty liver disease.
If future studies confirm these early findings, the drug could one day help doctors not only slow liver disease but possibly reverse some of the damage. Until then, healthy daily habits remain the strongest protection for keeping the liver healthy.
If you care about liver health, please read studies about simple habit that could give you a healthy liver, and common diabetes drug that may reverse liver inflammation.
For more information about health, please see recent studies about simple blood test that could detect your risk of fatty liver disease, and results showing this green diet may strongly lower non-alcoholic fatty liver disease.
Copyright © 2026 Knowridge Science Report. All rights reserved.
